Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio, Kirit M. Ardeshna, Mehdi Hamadani, Brian Hess, Brad S. Kahl, John Radford, Melhem Solh, Anastasios Stathis, Pier Luigi Zinzani, Karin Havenith, Jay Feingold, Shui He, Yajuan Qin, David Ungar, Xiaoyan Zhang, Carmelo Carlo‐Stella
Topics & Concepts
MedicineRefractory (planetary science)Clinical endpointInternal medicineDiffuse large B-cell lymphomaPopulationPhases of clinical researchClinical trialLymphomaOncologySurgeryAstrobiologyEnvironmental healthPhysicsLymphoma Diagnosis and TreatmentCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies Research